Drug Approval | May 26, 2022
Zydus Lifesciences receives final approval from USFDA for Pemetrexed for Injection
Pemetrexed for Injection has a market size of USD 1,236 mn (as per IQVIA MAT March’22)
Pemetrexed for Injection has a market size of USD 1,236 mn (as per IQVIA MAT March’22)
The key categories include intimate wellness, skincare & hair care
_256_384.jpg)
The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
Nulibry is approved by the U.S. Food and Drug Administration (USFDA) to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening paediatric genetic disorder
Zydus unveils its ‘innovation and care’ centric corporate brand identity
Astec LifeSciences has reported its financial performance for the quarter ended December 31, 2021
The company expects a potential sales turnover of Rs.350-500 crores at 100 % capacity utilization
The new greenfield manufacturing facility will be operated alongside the Guwahati facility as a parallel unit thereby helping mitigate the risks of a single-location operation
The company posted net profit of Rs.16.18 crores for the period ended June 30, 2020.
Subscribe To Our Newsletter & Stay Updated
